Researchers successfully developed a machine learning-based method for predicting symptom deterioration in patients with cancer.

We show that, compared with surgeon predictions and existing risk-prediction tools, our machine-learning model can enhance ...

Adding the PCSK9 inhibitor evolocumab to a high-intensity, cholesterol-lowering regimen reduced the risk of a first major ...